Meek David D. 4
4 · Mirati Therapeutics, Inc. · Filed Jan 19, 2023
Insider Transaction Report
Form 4
Meek David D.
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2023-01-17$42.38/sh−3,179$134,715→ 61,792 total
Footnotes (1)
- [F1]Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 14, 2022.